Fresenius Medical Care AG
FMS
$23.87
-$0.48-1.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.55B | 5.29B | 5.90B | 5.71B | 5.44B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.55B | 5.29B | 5.90B | 5.71B | 5.44B |
| Cost of Revenue | 4.05B | 3.94B | 4.29B | 4.26B | 4.06B |
| Gross Profit | 1.50B | 1.35B | 1.62B | 1.45B | 1.38B |
| SG&A Expenses | 840.20M | 859.47M | 913.38M | 824.74M | 898.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.23M | 19.15M | -31.32M | -3.14M | -11.50M |
| Total Operating Expenses | 4.95B | 4.86B | 5.21B | 5.12B | 4.99B |
| Operating Income | 597.75M | 430.98M | 689.18M | 586.57M | 447.62M |
| Income Before Tax | 437.21M | 238.14M | 591.90M | 470.65M | 397.85M |
| Income Tax Expenses | 102.54M | 49.06M | 123.91M | 87.95M | 88.82M |
| Earnings from Continuing Operations | 334.67M | 189.08M | 467.99M | 382.70M | 309.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -85.38M | -54.21M | -87.24M | -61.43M | -53.37M |
| Net Income | 249.29M | 134.87M | 380.75M | 321.27M | 255.67M |
| EBIT | 597.75M | 430.98M | 689.18M | 586.57M | 447.62M |
| EBITDA | 1.00B | 835.20M | 908.19M | 997.91M | 851.18M |
| EPS Basic | 0.93 | 0.49 | 1.33 | 1.10 | 0.87 |
| Normalized Basic EPS | 0.74 | 0.67 | 1.07 | 0.95 | 0.66 |
| EPS Diluted | 0.92 | 0.49 | 1.33 | 1.10 | 0.87 |
| Normalized Diluted EPS | 0.74 | 0.67 | 1.07 | 0.95 | 0.66 |
| Average Basic Shares Outstanding | 268.44M | 275.25M | 285.91M | 292.10M | 293.41M |
| Average Diluted Shares Outstanding | 268.44M | 275.25M | 285.91M | 292.10M | 293.41M |
| Dividend Per Share | -- | -- | 1.73 | -- | -- |
| Payout Ratio | 183.24% | -- | 0.00% | 0.00% | 187.56% |